期刊档案

INNOVATIONS in Pharmacy

ISSN 2155-0417 · University of Minnesota Libraries Publishing · United States

INNOVATIONS in Pharmacy 钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 16 周,2025 年发文 44 篇,期刊官网显示暂停或关闭投稿。

期刊官网显示暂停或关闭投稿:Innovations in Pharmacy is closed for submissions. Thank you to our readers, authors, reviewers and editors, as well as U of M Publishing Services, for supporting 16 years of publishing! 原文 ↗出版商官网 ·

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区—暂无 CiteScore 排名
审稿周期约 16 周投稿社区平均反馈
版面费免版面费钻石开放获取(无 APC)
录用比例—暂无反馈
年发文量44 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

INNOVATIONS in Pharmacy 由 University of Minnesota Libraries Publishing 出版。按 OpenAlex 近年发文统计,该刊主要发表 Pharmacy and Medical Practices、Pharmaceutical Practices and Patient Outcomes、Innovations in Medical Education 等主题的论文,这 3 个主题约占 57.5%,主导子领域为 Economics and Econometrics。(根据 OpenAlex 主题统计与中科院分区数据生成)

INNOVATIONS in pharmacy is a peer-reviewed, quarterly publication. Therefore, we encourage the submission of manuscripts that posit new ideas and new ways for addressing both challenges and opportunities in pharmacy practice, education, and policy. We especially encourage manuscripts that will alter perceptions, shift expectations or change the way we approach pharmacy practice, education or policy. INNOVATIONS in pharmacy is an open-access journal, which means that all content is freely available without charge to the user or their institution. Users are allowed to read, download, copy, distribute, print, search, link to the full texts of the articles, or use them for any other lawful purpose without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access. In addition, we support Creative Commons licensing. If an article is licensed under a Creative Commons license, the article may be reused in accordance with the terms of that license. For permission for other uses or questions about use, please contact the individual authors. For all other questions, please contact the editors at schom010@umn.edu. Manuscripts accepted for publication are posted on the website immediately upon final acceptance. Every quarter (Winter, Spring, Summer, Fall), an issue will be closed, and a table of contents for each issue will be prepared. A table of contents will be emailed when an issue becomes finalized. This journal follows the recommendations in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE). We also ask reviewers to follow the COPE Ethical Guidelines for Peer Reviewers. The journal does not accept advertising. Articles will be identified by the following topic areas: Community Engagement: scholarship that involves a researcher in a mutually beneficial partnership with the community Education: advancing teaching and learning methods with various audiences, including student pharmacists, residents, and graduate students. Formulary Evaluations: proposing and evaluating modern, scientific methods for determining the evidence base for the fair pricing and accessibility of pharmaceutical products and medical devices. Leadership: creating ways for people to contribute to making extraordinary things happen Pharmacy Practice & Practice-Based Research: developing the professional roles of pharmacists; scholarship

摘自期刊官网 Aims & Scope

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics32.9%
  2. Pharmaceutical Practices and Patient OutcomesMedicine13.4%
  3. Innovations in Medical EducationMedicine11.2%
  4. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance6.2%
  5. Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.6%
  6. Medication Adherence and ComplianceMedicine4.6%
  7. Interprofessional Education and CollaborationHealth Professions3.2%
  8. Patient Safety and Medication ErrorsHealth Professions2.2%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

DOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

h-index
25OpenAlex ·
i10-index
173OpenAlex ·
两年平均被引
1.04OpenAlex ·
Gold OA 文章占比
0%LetPub ·

逐年发文量 OpenAlex 统计 · 累计 977 篇 · 当年数据不完整

年份发文量其中 OA被引
20263030537
20254444716
20244949662
20235050681
20227272525
20219292524

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
16 WeeksLetPub ·
投稿到发表(期刊自报)
约 16 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

钻石开放获取(无 APC)DOAJ

所有文章开放获取,且不向作者收取文章处理费。

来源文章处理费费用减免许可证观测时间
DOAJ无文章处理费无CC BY-NC
LetPub无文章处理费无—
出版商官网无文章处理费——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点3 项,摘自作者指南
摘要
250–300 词
参考文献格式
AMA 格式
投稿信(Cover letter)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型14 种
  1. book reviewBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  2. book reviewsBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  3. case studiesBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  4. case studyBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  5. clinical experiencesBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  6. commentaryBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  7. idea papersBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  8. instructional toolBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  9. letterBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  10. lettersBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  11. notesBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  12. original researchBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  13. review articleBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
  14. review articlesBook Reviews Case Studies Clinical Experiences Commentary Idea Papers Instructional Tool Letters Notes Original Research Review Articles未说明篇幅
出版商官网
官网政策摘录利益冲突、出版伦理、许可与版权、开放获取、自存档
利益冲突 CONFLICT OF INTEREST STATEMENT

作者必须声明任何可能影响工作中所呈现的信息、研究、分析或解释的利益冲突,并应在作品封面页披露;利益冲突指主要利益(如研究的有效性)的专业判断可能受次要利益(如经济利益)影响;如无可声明,请在封面页注明“Conflicts of Interest: None”。 模型中文摘要

Authors must declare any conflicts of interest that may affect the information, research, analysis, or interpretation presented in the work. The cover page of the work should disclose any conflicts of interest. A conflict of interest exists when professional judgment concerning a primary interest (such as the validity of the research) may be influenced by secondary interests (such as financial gai…

原文 ↗出版商官网 ·
出版伦理

作者确认涉及人类受试者的研究项目已经过机构审查委员会(IRB)审查,以确保两项基本标准得到遵守:一是受试者不承受不当风险,二是受试者给予非强迫的知情同意。 模型中文摘要

The author affirms that an Institutional Review Board (IRB) has reviewed research projects which involve human subjects to ensure that two broad standards are upheld: first, that subjects are not placed at undue risk; second, that they give uncoerced, informed consent to their participation.

原文 ↗出版商官网 ·
许可与版权 Copyright and Use of Articles

Innovations in Pharmacy 发表的所有文章均以知识共享非商业性署名(CC BY-NC 4.0)许可发布,作者保留其作品的版权;用户有权共享或改编文章,但须署名作者和来源且仅限非商业用途,此类非商业用途无需许可,其他用途需联系作者或编辑。 模型中文摘要

All articles published in Innovations in Pharmacy are distributed with a Creative Commons Noncommercial Attribution (CC BY-NC 4.0) license meaning that authors hold the copyright to their work. This also means that users have the right to share or adapt the article, as long as the author(s) and source are cited and the use is for noncommercial purposes. Permission is not needed for these noncommer…

原文 ↗出版商官网 ·
开放获取 Open Access Policy

Innovations in Pharmacy 提供即时开放获取,所有内容对用户或其机构免费提供,且不收取文章处理费;所有文章均采用知识共享非商业性署名许可(CC BY-NC 4.0)。 模型中文摘要

Innovations in Pharmacy provides immediate open access to its content, which means that all content is freely available without charge to the user or their institution. This also means that Innovations in Pharmacy does not charge article processing fees. All articles are licensed under a Creative Commons Noncommercial Attribution license (CC BY-NC 4.0)

原文 ↗出版商官网 ·
自存档 Self-Archiving Policy

每篇文章的版权属于作者,作者有权将文章存入其机构知识库或任何合适的学科知识库,前提是不得违反与该文章相关联的 CC 许可的要求。 模型中文摘要

The copyright of each article belongs to the author(s) and grants each author the right to deposit the article in their institutional repository or any suitable subject repository, provided they do not contravene the requirements of the CC license associated with the article.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
University of Minnesota Libraries Publishing
出版国家或地区
United States
出版语言
English
ISSN
2155-0417
官网最新一期
Volume 17, Issue 1(2026 年)
官方链接

常见问题

关于 INNOVATIONS in Pharmacy 的常见问题

INNOVATIONS in Pharmacy 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 16 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

INNOVATIONS in Pharmacy 的投稿格式要求是什么?

据期刊作者指南:摘要:250–300 词;参考文献格式:AMA 格式;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

INNOVATIONS in Pharmacy 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,INNOVATIONS in Pharmacy 被 DOAJ 收录。

INNOVATIONS in Pharmacy 是开放获取期刊吗?版面费多少?

INNOVATIONS in Pharmacy 为钻石开放获取(无 APC)。不收取文章处理费。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。